Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study.
Angeliki BolouZoe DrymoussiDoris LanzChiamaka Esther AmaefuleFrancisco Jose Gonzalez CarrerasMaria Del Carmen Pardo LlorenteJulie DoddsElena PizzoAmy ThomasJames HeighwayAngela HardenAnita SanghiGraham HitmanJavier ZamoraTeresa Pérez-PérezMohammed S B HudaShakila ThangaratinamPublished in: BMJ open (2023)
ISRCTN20930880.
Keyphrases
- double blind
- placebo controlled
- phase iii
- phase ii
- study protocol
- type diabetes
- pregnancy outcomes
- clinical trial
- polycystic ovary syndrome
- preterm infants
- phase ii study
- randomized controlled trial
- glycemic control
- insulin resistance
- pregnant women
- cross sectional
- cardiovascular disease
- open label
- cervical cancer screening
- case control
- squamous cell carcinoma
- radiation therapy
- metabolic syndrome